Erudio Healtherudio.com
Sponsor
Peter MacCallum Cancer Centre, Australia trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Peter MacCallum Cancer Centre, Australia yet. Erudio has found public clinician commentary on 10 clinical trials sponsored by Peter MacCallum Cancer Centre, Australia, including AIM, LuCAB, LuTectomy and NAPSTER. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Peter MacCallum Cancer Centre, Australia). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| LuTectomy NCT04430192 · Peter MacCallum Cancer Centre, Australia DeepView → | high-risk localised prostate cancer | Phase 1/Phase 2 | Deep | View | |||
| LuCAB NCT05340374 · Peter MacCallum Cancer Centre, Australia DeepView → | metastatic castration-resistant prostate cancer | Phase 1/Phase 2 | Deep | View | |||
| AIM NCT02471391 · Peter MacCallum Cancer Centre, Australia StandardView → | relapsed or refractory mantle cell lymphoma | Phase 2 | Standard | View | |||
| NAPSTER NCT05024318 · Peter MacCallum Cancer Centre, Australia FocusedView → | clear cell renal cell carcinoma | Phase 2 | Focused | View | |||
| UpFrontPSMA NCT04343885 · Peter MacCallum Cancer Centre, Australia FocusedView → | metastatic hormone-sensitive prostate cancer | Phase 2 | Focused | View | |||
| AlphaBet NCT05383079 · Peter MacCallum Cancer Centre, Australia FocusedView → | metastatic castration-resistant prostate cancer | Phase 1/Phase 2 | Focused | View | |||
| PLIMATH NCT03331731 · Peter MacCallum Cancer Centre, Australia FocusedView → | Hodgkin lymphoma unsuitable for ABVD | Phase 2 | Focused | View | |||
| PRINCE NCT03658447 · Peter MacCallum Cancer Centre, Australia FocusedView → | metastatic castration resistant prostate cancer | Phase 1/Phase 2 | Focused | View | |||
| LuPARP NCT03874884 · Peter MacCallum Cancer Centre, Australia FocusedView → | metastatic castration-resistant prostate cancer | Phase 1 | Focused | View | |||
| C-SMART NCT04534725 · Peter MacCallum Cancer Centre, Australia FocusedView → | COVID-19 in cancer patients | Phase 3 | Focused | View | |||